|  Help  |  About  |  Contact Us

Publication : Novel INHAT repressor (NIR) is required for early lymphocyte development.

First Author  Ma CA Year  2014
Journal  Proc Natl Acad Sci U S A Volume  111
Issue  38 Pages  13930-5
PubMed ID  25201955 Mgi Jnum  J:216490
Mgi Id  MGI:5608866 Doi  10.1073/pnas.1310118111
Citation  Ma CA, et al. (2014) Novel INHAT repressor (NIR) is required for early lymphocyte development. Proc Natl Acad Sci U S A 111(38):13930-5
abstractText  Novel inhibitor of histone acetyltransferase repressor (NIR) is a transcriptional corepressor with inhibitor of histone acetyltransferase activity and is a potent suppressor of p53. Although NIR deficiency in mice leads to early embryonic lethality, lymphoid-restricted deletion resulted in the absence of double-positive CD4(+)CD8(+) thymocytes, whereas bone-marrow-derived B cells were arrested at the B220(+)CD19(-) pro-B-cell stage. V(D)J recombination was preserved in NIR-deficient DN3 double-negative thymocytes, suggesting that NIR does not affect p53 function in response to physiologic DNA breaks. Nevertheless, the combined deficiency of NIR and p53 provided rescue of DN3L double-negative thymocytes and their further differentiation to double- and single-positive thymocytes, whereas B cells in the marrow further developed to the B220(+)CD19(+) pro-B-cell stage. Our results show that NIR cooperate with p53 to impose checkpoint for the generation of mature B and T lymphocytes.
Quick Links:
 
Quick Links:
 

Expression

Publication --> Expression annotations

 

Other

13 Bio Entities

Trail: Publication

0 Expression